Abstract
Fifteen patients with metastatic renal cell carcinoma were treated with Baker's antifol at a dose schedule of 250 mg/m2 iv for 3 days every 3 weeks. One objective response was seen, and toxicity was minimal. No usefulness of Baker's antifol in the treatment of metastatic renal cell carcinoma was demonstrated.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adult
-
Aged
-
Diarrhea / chemically induced
-
Drug Evaluation
-
Female
-
Granulocytes
-
Humans
-
Kidney Neoplasms / drug therapy*
-
Leukocyte Count
-
Male
-
Middle Aged
-
Nausea / chemically induced
-
Platelet Count
-
Triazines / adverse effects
-
Triazines / therapeutic use*
-
Vomiting / chemically induced